Literature DB >> 25451712

DICER1 mutations in a patient with an ovarian Sertoli-Leydig tumor, well-differentiated fetal adenocarcinoma of the lung, and familial multinodular goiter.

Yingchen Wu, Dongmei Chen, Yangzhi Li, Lijuan Bian, Tingting Ma, Meiqing Xie.   

Abstract

DICER1 syndrome, a recently described tumor-predisposition syndrome, often involves multiple organs and is characterized by pleuropulmonary blastoma (PPB), cystic nephroma, ovarian Sertoli-Leydig tumors, familial multinodular goiter, etc. Germline DICER1 mutations have been identified in individuals with a variety of malignant conditions. However, in a review of the reported DICER1 syndrome cases that feature an unusual array of neoplastic and hyperplastic phenotypes, no mentions are made of these patients also presenting well-differentiated fetal adenocarcinoma of the lung. Here, we present a 16-year-old Chinese adolescent suffering from an ovarian Sertoli-Leydig cell tumor,well-differentiated fetal adenocarcinoma of the lung, and familial multinodular goiter with a nonsense mutation (c.3540C > A; p.Tyr1180*) in exon 21 of DICER1. This report presents the first case in which the clinical features of DICER1 syndrome appear in combination with well-differentiated fetal adenocarcinoma of the lung. We hypothesize that this case may suggest that well-differentiated fetal adenocarcinoma of the lung falls within the wide spectrum of manifestations of the DICER1 syndrome. Remarkably, this mutation is reported in a patient from The International PPB Registry. 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25451712     DOI: 10.1016/j.ejmg.2014.09.008

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  8 in total

Review 1.  Germline Genetics and Childhood Cancer: Emerging Cancer Predisposition Syndromes and Psychosocial Impacts.

Authors:  Sarah G Mitchell; Bojana Pencheva; Christopher C Porter
Journal:  Curr Oncol Rep       Date:  2019-08-15       Impact factor: 5.075

Review 2.  Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli-Leydig Cell Tumor.

Authors:  Elisa De Paolis; Rosa Maria Paragliola; Paola Concolino
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

3.  Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.

Authors:  Nicholas E Khan; Andrew J Bauer; Kris Ann P Schultz; Leslie Doros; Rosamma M Decastro; Alexander Ling; Maya B Lodish; Laura A Harney; Ron G Kase; Ann G Carr; Christopher T Rossi; Amanda Field; Anne K Harris; Gretchen M Williams; Louis P Dehner; Yoav H Messinger; D Ashley Hill; Douglas R Stewart
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 4.  Inherited Follicular Epithelial-Derived Thyroid Carcinomas: From Molecular Biology to Histological Correlates.

Authors:  José Manuel Cameselle-Teijeiro; Ozgur Mete; Sylvia L Asa; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2021-01-25       Impact factor: 3.943

5.  A complex DICER1 syndrome phenotype associated with a germline pathogenic variant affecting the RNase IIIa domain of DICER1.

Authors:  Emeli Pontén; Sofia Frisk; Fulya Taylan; Raquel Vaz; Sandra Wessman; Leanne de Kock; Niklas Pal; William D Foulkes; Kristina Lagerstedt-Robinson; Ann Nordgren
Journal:  J Med Genet       Date:  2020-11-18       Impact factor: 6.318

6.  Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and DICER1 Mutations: Case Report and Literature Review.

Authors:  Yanglin Ni; Xuan Zhou; Ling Wu; Ping Wu; Ying Liu; Yinnan Li; Li Cai; Xueshu Fu; Chunhua Zhang
Journal:  Pharmgenomics Pers Med       Date:  2021-08-03

7.  Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.

Authors:  Shuyang Zhang; Huihui Yin; Jing Zhang; Lu Yang; Guangjian Yang; Jia Jia; Yuchen Jiao; Jianming Ying; Yan Wang
Journal:  Thorac Cancer       Date:  2021-08-31       Impact factor: 3.500

Review 8.  DICER1 Syndrome: DICER1 Mutations in Rare Cancers.

Authors:  Jake C Robertson; Cheryl L Jorcyk; Julia Thom Oxford
Journal:  Cancers (Basel)       Date:  2018-05-15       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.